50% Savings with IV Memberships! Learn More
Take a step towards a healthier future with Tirzepatide. Schedule a consultation today!
$450 for 30 day supply
Tirzepatide is the active ingredient in Mounjaro and Zepbound. Tirzepatide activates receptors of hormones secreted from the intestine to reduce appetite and food intake.
Tirzepatide has been shown to affect appetite regulation, leading to reduced food intake, which can contribute to weight loss. Tirzepatide can also improve glycemic control, reduce insulin resistance, and have favorable effects on other metabolic parameters, contributing to rapid weight loss.
In order to obtain a compounded medication, you will need to get a new prescription from your doctor. We provide labs, doctor consult, and medication with our program along with unlimited follow-up.
In clinical trials, Tirzepatide reduced body weight by an average of almost 21% in people who were overweight or had obesity. “That's the most weight loss we've ever seen with a medication,” says Louis Aronne at Weill Cornell Medicine in New York.
Although both semaglutide and tirzepatide have been used in the treatment of type 2 diabetes, their mechanisms of action are not identical. Tirzepatide is sold under the brand name Mounjaro and may offer an extra weight loss boost. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the GLP-1 hormone and makes you feel less hungry.
Mounjaro starts to work as soon as you take your first dose, but not everyone notices an effect immediately. The dose of the medication is gradually increased each month so that the body can adjust to the medication while reducing the risk of more severe side effects that can occur if a higher dose is taken too soon.
While we cannot accept insurance, we do accept HSA and FSA payments.